Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Vitiligo treatments are improving but still face challenges and high relapse rates.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Immunoadsorption successfully treated a man's resistant polymyositis.

Blocking interferon-gamma might help treat various autoimmune diseases.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Anti-CD19 therapy may help treat SLE and NMOSD.

BMS-470539 reduces skin fibrosis and inflammation.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Belimumab may cause hair loss in lupus patients.

New therapies like JAK inhibitors and stem cells show promise for treating vitiligo.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.